Realbotix Consensus Price Target Cut by 20.53% to $0.42

The average one-year price target for Realbotix (OTCPK:XBOTF) (DB:76M0) has been revised to $0.42 / share. This is a decrease of 20.53% from the prior estimate of $0.53 dated January 13, 2026. These figures represent aggregate analyst targets compiled from various researchers and do not constitute a recommendation by Fintel.

The price target is an average of many targets provided by analysts. The latest targets range from a low of $0.41 to a high of $0.43 / share. This represents a narrowing of the target range, with the current target range width at $0.02, compared to the prior target range width of $0.02. The median price target also decreased to $0.42 from the prior median of $0.53.

Looking at the historical trajectory of the consensus target, the mean target was $0.53 on December 6, 2025, which represents the observed twelve-month high mean. It subsequently moved to $0.52 on December 21, 2025, and returned to $0.53 on January 14, 2026. The target change since the 90-day baseline date of January 14, 2026, is -20.53%. The current mean of $0.42, recorded on October 24, 2026, represents the observed twelve-month low mean.

Realbotix operates within the Information Technology sector, specifically the Electronic Equipment & Instruments sub-industry. Within this sub-industry, there are 31 companies covered by analysts. Of these, 11 companies have had their targets raised, 11 have been lowered, and 9 remain unchanged. The sub-industry median revision percent is 0.00%, while the sub-industry median implied change percent is +71.57%.

The analyst recommendation trend has remained steady. As of the current recommendation period of October 1, 2026, the company has a total of 5 recommendations, consisting of 1 strong buy, 3 buy, and 1 hold, with no sell or strong sell recommendations. This distribution reflects 80.0% positive recommendations, 20.0% hold recommendations, and 0.0% negative recommendations, which is unchanged from the prior recommendation period of September 1, 2026.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Realbotix Corp. Find out what the Options Markets think of Realbotix Corp. See our take on Realbotix Corp. Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available